Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be willing to sign a consent form agreeing to take part in the study
- You must be 18 years old or older at the time of signing the consent form
- You must have been diagnosed with a solid tumour (such as breast cancer or lung cancer)
- You must be scheduled to receive a chemotherapy drug called paclitaxel, given through a drip (IV), once every 3 weeks
Who may not be able to join:
- You have previously received certain chemotherapy drugs (such as taxane-based, platinum-based, or anti-microtubule drugs) that are known to cause nerve damage
- You have a history of nerve damage or nerve-related problems (called neuropathy)
- You have a history of carpal tunnel syndrome (a condition causing numbness or tingling in the hand and wrist)
- You have a history of allergic reactions to latex or gloves
- You are currently receiving any treatments that may help nerve-related conditions, such as certain medications (for example amitriptyline, gabapentin), supplements, acupuncture, cold therapy, or exercise therapy
- You have a history of Raynaud's phenomenon (a condition where fingers and toes change colour and feel numb in the cold)
- You have wounds or large scars on your hands
- You are currently pregnant or breastfeeding
- You have poorly controlled diabetes, shown by a blood sugar level measurement called HbA1c being above 6.5 (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sunatee Sa-nguansai, M.D., Department of Medical Services Ministry of Public Health of Thailand
Phone: +66805564241
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of grade 2 or higher paclitaxel-induced sensory peripheral neuropathy using CTCAE version 5.0.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.